Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.8 0 (0%) Market Cap: 5.66 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 19.11 GF Score: 70/100

Ionis Pharmaceuticals Inc at Evercore ISI HealthCONx Conference Transcript

Dec 01, 2020 / 07:40PM GMT
Release Date Price: $51.12 (+1.17%)
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

Welcome, everyone. This is Josh Schimmer from the Evercore ISI biotech team. I'm very pleased to be joined by Brett Monia, Chief Executive Officer of Ionis; and Beth Hougen, Chief Financial Officer.

Ionis' pipeline is really turning into a breathtaking journey through science. I've absolutely loved doing some of the webcast that we've done with Ionis scientists really digging into each of the programs in the pipeline and really understanding the nuts and bolts, the genetics, the biology and the commercial outlook. It really feels like Ionis is a very different Ionis this year than it was 2 or 3 years ago and 5 and 10 years ago. I know a lot of that is driven by this evolving platform.

Questions & Answers

Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

So Brett, maybe you can just kind of give us the snapshot of how the antisense platform at Ionis has changed from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot